BioSpace News Archive

Lightstone Ventures recently announced the closing of Lightstone Ventures III, securing $375 million to invest in early-stage firms that develop high-impact technologies that can change lives.

Several life sciences companies were sprinkled throughout this year’s list. Here’s a look at a few of the honorees.

Scopus BioPharma Inc. today announced the appointments of John Rossi, Ph.D. and Nagy Habib, Ch.M., F.R.C.S. to the Scientific Advisory Board of Duet Therapeutics.

Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, today announced that management will present at the Cantor Global Healthcare Conference on Thursday, September 30, 2021 at 1:20 pm ET.

Virpax® Pharmaceuticals Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the pricing of an underwritten public offering of 6,670,000 shares of its common stock at a public offering price of $6.00 per share, for gross proceeds of $40,020,000 million, before deducting underwriting discounts and offering expenses.

IntraBio Inc announced positive results from the full data set for its multinational clinical trial of IB1001 for the treatment of GM2 Gangliosidosis.

Therma Bright will commence trading on the OTCQB with the market open on September 14, 2021, under the symbol “TBRIF”.

Centinel Spine ® today announced the first international implantation of the 3D-Printed Porous Titanium FLX ™ platform.

Axiom Real-Time Metrics (“Axiom”), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting at the Clinical Trials in Rare Diseases Conference on September 14th, 2021.

Evoke, a leading global health and wellness agency, announced today that Karla Turner Anderson , JD, CDP, has joined the company as Senior Vice President Diversity, Equity and Inclusion.